FDA Import Refusal AEK-7977936-6/11/1 — Cipla Limited
The FDA refused shipment AEK-7977936-6/11/1 from Cipla Limited (India) on November 4, 2020. The refused product falls under Drugs and Biologics — TADALAFIL. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- November 4, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66SDY51 TADALAFIL
- Charges
- 75